Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Jul 31, 2026
SQQQ's $60 Target: Evaluating the Potential +50% Upside from Recent Levels

SQQQ's $60 Target: Evaluating the Potential +50% Upside from Recent Levels

Key Takeaways

  • Price target: $60 represents a roughly 50% upside from SQQQ's recent trading range near $40 and coincides with a key psychological and technical zone.
  • Bullish catalyst: A meaningful Nasdaq-100 correction of 15–20% could propel SQQQ toward the $60 level, given the ETF's -3x daily leveraged inverse structure.
  • Key obstacle: The persistent long-term uptrend in technology equities and the structural decay inherent in leveraged ETFs make sustained rallies in SQQQ exceptionally difficult to maintain.
  • Critical resistance: The 50-day moving average near $44 and the 200-day moving average around $62 serve as major technical barriers on any upward move.
  • Bottom line: While $60 is achievable during a sharp Nasdaq pullback, holding that level requires a sustained market downturn—something that has repeatedly eluded bearish positions over the past several years.

Why the $60 Level Draws Attention

The $60 price target for the ProShares UltraPro Short QQQ ETF (SQQQ) has become a focal point among traders tracking the technology-heavy Nasdaq-100 for signs of weakness. SQQQ is a -3x daily leveraged inverse ETF, meaning it seeks to deliver three times the opposite of the Nasdaq-100's daily percentage move. When the Nasdaq-100 falls 1%, SQQQ is designed to rise approximately 3%—and when the index rallies, SQQQ falls three times as fast.

With SQQQ trading near $40 in late July 2026 and a 52-week range spanning from $35.80 to $98.85, the $60 target sits roughly midway between the recent trough and the prior peak. It represents a level where bearish conviction would need to intensify considerably, translating into a roughly 15–20% correction in the underlying Nasdaq-100 index depending on the path and duration of the decline.

The Mechanics Behind SQQQ's Leveraged Structure

Before evaluating whether $60 is realistic, investors must understand what SQQQ actually holds. Rather than owning shares of individual companies, SQQQ uses derivatives—primarily swap agreements and futures contracts—to achieve its -3x daily objective. The fund's largest exposures mirror the Nasdaq-100's top constituents in reverse: when mega-cap names like Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla decline, SQQQ benefits disproportionately.

This structure also introduces daily compounding effects. Over periods longer than a single trading session, SQQQ's returns can deviate significantly from a simple -3x multiple of the Nasdaq-100's cumulative return. In trending markets—either up or down—this compounding can work in the holder's favor. In choppy, range-bound markets, however, the constant resetting of daily leverage erodes value through a phenomenon known as volatility decay. Over the past three years, SQQQ has declined roughly 89%, even though the Nasdaq-100 experienced periods of drawdown during that span. I also checked comparable patterns using Tickeron’s AI Pattern Search Engine to see how similar setups have played out historically.

Potential Catalysts for a Move to $60

Several macro conditions could trigger the kind of Nasdaq-100 selloff necessary to push SQQQ toward $60. A resurgence of inflation forcing the Federal Reserve to maintain or raise interest rates would pressure the growth-oriented technology stocks that dominate the Nasdaq-100. High valuations among the index's largest constituents—many trading at elevated price-to-earnings multiples—leave them vulnerable to multiple compression if earnings disappoint or bond yields climb.

Geopolitical tensions, trade policy disruptions, or a deterioration in corporate earnings growth could also catalyze a rotation out of risk assets. Technology stocks have benefited enormously from artificial intelligence enthusiasm, but any slowdown in AI-related capital expenditure or monetization progress could puncture that narrative. A 15–20% Nasdaq-100 correction from recent levels would, in a relatively smooth decline, translate to SQQQ approaching or breaching the $60 threshold.

Barriers to Reaching and Holding $60

The most formidable headwind facing SQQQ is the multi-year structural uptrend in U.S. equities, particularly in technology. The Nasdaq-100 has proven remarkably resilient, supported by consistent earnings outperformance from mega-cap technology companies, share buyback programs, and persistent investor appetite for growth exposure. Even during periods of elevated volatility, dip-buying has historically overwhelmed selling pressure before bearish positions could fully capitalize.

Additionally, SQQQ carries a 0.95% net expense ratio and experiences the compounding decay discussed earlier. Holding the ETF for weeks or months while waiting for a correction erodes capital even if the Nasdaq-100 moves sideways. The fund's total net assets of approximately $2 billion reflect its role primarily as a tactical hedging or short-term trading instrument rather than a buy-and-hold investment.

Key Technical Levels to Watch

From a technical analysis standpoint, SQQQ faces immediate resistance near the $44 level, which aligns with the 50-day simple moving average. A decisive break above that zone would signal strengthening bearish momentum in the underlying index. Further overhead, the 200-day moving average near $62 forms a major structural barrier—remarkably close to the $60 target. This convergence of a psychological round number with a widely followed long-term moving average makes the $60–$62 zone a significant supply area where sellers may emerge aggressively.

On the downside, support near $36–$38 has held multiple times in recent months, marking the lower boundary of SQQQ's current range. A breakdown below that floor would invalidate the bullish case and likely coincide with new highs in the Nasdaq-100. From what I see in the charts, these levels remain critical markers.

Historical Performance and Sentiment

SQQQ's long-term price history tells a stark story about the difficulty of betting against the Nasdaq-100. The ETF has undergone multiple reverse stock splits since its 2010 inception to maintain a tradeable share price, reflecting the cumulative erosion caused by rising equity markets. The fund's 52-week high of $98.85 was reached during a period of pronounced Nasdaq weakness in mid-2025, demonstrating how rapidly SQQQ can spike when conditions align—but also how fleeting those spikes tend to be.

Current market sentiment, as reflected in options positioning and fund flows, continues to lean bullish on technology. Any shift toward sustained bearishness would likely need to be preceded by a deterioration in forward earnings guidance from the mega-cap leadership group or a clear macroeconomic catalyst.

AI Daily Buy/Sell Signals

In my own analysis of volatile instruments like SQQQ, I turn to Tickeron’s AI Daily Buy/Sell Signals to generate timely, data-driven insights. The system continuously monitors thousands of stocks and ETFs, including leveraged and inverse products, producing Buy, Sell, or Hold signals based on technical patterns, trend strength, and AI models. This helps me identify emerging opportunities and manage positions with greater discipline in fast-moving markets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SQQQ

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


SQQQ's RSI Indicator dives oversold zone

The RSI Indicator for SQQQ moved into overbought territory on October 05, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where SQQQ advanced for three days, in 228 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

SQQQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 127 of 143 cases where SQQQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SQQQ as a result. In 80 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for SQQQ turned negative on September 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 42 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

SQQQ moved below its 50-day moving average on September 17, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SQQQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the NASDAQ-100 Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization. The fund is non-diversified.
View a ticker or compare two or three
SQQQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Inverse Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks
Shares of Robinhood Markets are down approximately 6.15% in Thursday's intraday session, trading around $65.80 after closing at $70.11 on April 1, 2026. Wolfe Research delivered a sharp blow by cutting its price target on HOOD by 30%, citing persistent weakness in crypto trading volumes as a core drag on revenue.